Abstract
The primary aim of the VIP-HF study was to examine the incidence of sustained ventricular tachyarrhythmias (VTs) in heart failure (HF) with mid-range (HFmrEF) or preserved ejection fraction (HFpEF). Secondary aims were to examine the incidence of non-sustained VTs, bradyarrhythmias, HF hospitalizations and mortality. This was an investigator-initiated, prospective, multicentre, observational study of patients with HF and left ventricular ejection fraction (LVEF) >40%. Patients underwent extensive phenotyping, after which an implantable loop recorder was implanted. We enrolled 113 of the planned 250 patients [mean age 73 ± 8 years, 51% women, New York Heart Association class II/III 54%/46%, median N-terminal pro B-type natriuretic peptide 1367 (710-2452) pg/mL and mean LVEF 54 ± 6%; 75% had LVEF >50%]. Eighteen percent had non-sustained VTs and 37% had atrial fibrillation on Holter monitoring. During a median follow-up of 657 (219-748) days, the primary endpoint of sustained VT was observed in one patient. The incidence of the primary endpoint was 0.6 (95% confidence interval 0.2-3.5) per 100 person-years. The incidence of the secondary endpoint of non-sustained VT was 11.5 (7.1-18.7) per 100 person-years. Five patients develope...Continue Reading
References
Sep 1, 1989·Journal of the American College of Cardiology·A GradmanS Goldstein
Jul 1, 1994·European Heart Journal·B M SzabóK I Lie
Dec 15, 1996·Circulation·H C DovalS V Perrone
Jan 5, 2000·Circulation·J R TeerlinkB M Massie
Oct 7, 2004·Circulation·Scott D SolomonMarc A Pfeffer
Jan 22, 2005·The New England Journal of Medicine·Gust H BardyUNKNOWN Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators
Feb 8, 2006·Circulation·Kenneth A EllenbogenUNKNOWN Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Jul 9, 2008·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Christopher M KramerUNKNOWN Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols
Mar 17, 2010·Circulation·Michael R ZileUNKNOWN I-Preserve Investigators
Sep 15, 2010·Circulation·Poul Erik Bloch ThomsenUNKNOWN Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study Group
Apr 24, 2013·European Journal of Heart Failure·Michelle M Y Chan, Carolyn S P Lam
May 8, 2014·European Heart Journal·Hein J J WellensArthur A Wilde
May 20, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Yehoshua C LevineAlfred E Buxton
Oct 11, 2014·European Journal of Heart Failure·Selcuk AdabagPeter E Carson
Sep 1, 2015·European Heart Journal·Silvia G PrioriDirk J Van Veldhuisen
May 22, 2016·European Journal of Heart Failure·Piotr PonikowskiUNKNOWN Document Reviewers
Feb 6, 2017·Journal of the American College of Cardiology·Muthiah VaduganathanJaved Butler
Mar 5, 2018·JACC. Heart Failure·Muthiah VaduganathanScott D Solomon
Apr 11, 2018·European Heart Journal Cardiovascular Imaging·Wouter P Te RijdtMaarten P van den Berg
Jun 16, 2018·European Heart Journal·Carolyn S P LamDirk J van Veldhuisen
Aug 3, 2018·European Journal of Heart Failure·Gijs van WoerdenMichiel Rienstra
Apr 15, 2019·JACC. Heart Failure·Li ShenJohn J V McMurray
May 31, 2019·Heart Failure Reviews·Antonis S ManolisHelen Melita
Sep 2, 2019·The Canadian Journal of Cardiology·Rahul SamantaVijay S Chauhan
Citations
Sep 7, 2020·European Journal of Heart Failure·Luanda P Grazette, Jeffrey J Goldberger
Jan 27, 2021·European Heart Journal·Michiel Rienstra, Isabelle C Van Gelder
Jan 20, 2021·European Journal of Heart Failure·Daniela TomasoniMarco Metra
Feb 11, 2021·European Journal of Heart Failure·Luis E RohdeScott D Solomon
May 2, 2021·European Journal of Heart Failure·Bart A MulderMichiel Rienstra
Jun 5, 2021·Clinical Cardiology·Gijs van WoerdenBerend Daan Westenbrink
Jul 23, 2021·Heart and Vessels·Gijs van WoerdenB Daan Westenbrink
Aug 10, 2021·Frontiers in Cardiovascular Medicine·Kaiyuan ZhuDachun Xu